Clinical Trial Record

Return to Clinical Trials

Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions


2013-01


2015-01


2015-01


121

Study Overview

Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions

The aim of this study is to compare Endoscopic Ultrasound and Fine Needle Aspirate with a standard 22-gauge needle using either "standard-suction" or ⋊pillary suction" methods for solid pancreatic lesions. Investigators hope to discover the best technique for obtaining diagnostic material when patients with a pancreatic mass undergo endoscopic ultrasound and fine needle aspirate procedure. There are currently several techniques for obtaining tissue during endoscopic ultrasound and fine needle aspirate. The procedure will be performed by either the capillary suction technique or no suction technique.

N/A

  • Pancreatic Solid Lesions
  • Pancreatic Mass
  • DEVICE: Standard technique EUS-FNA
  • DEVICE: Capillary suction technique for EUS FNA
  • NA_00079301

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2013-08-29  

2016-08-20  

2017-03-02  

2013-09-03  

2017-03-02  

2017-04-13  

2013-09-06  

2017-04-13  

2017-03  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Diagnostic


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
Single


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: Standard suction

These are patients who will have endoscopic ultrasound-guided fine needle aspiration using the standard suction FNA technique: 15 to-and-fro movements within the lesion will be performed with use of 10cc suction syringe.

DEVICE: Standard technique EUS-FNA

  • Standard suction Endoscopic Ultrasound- Fine Needle Aspiration (EUS-FNA) technique using the 22-gauge (Expect needle; Boston Scientific) needle: 15 to-and-fro movements within the lesion will be performed with use of 10cc suction syringe.
EXPERIMENTAL: Capillary suction

These are patients who will have endoscopic ultrasound-guided fine needle aspiration using the capillary suction FNA technique: 15 to-and-fro movements within the lesion will be performed with simultaneous minimal negative pressure provided by pulling the

DEVICE: Capillary suction technique for EUS FNA

  • Capillary suction Endoscopic Ultrasound- Fine Needle Aspiration (EUS-FNA) technique using the 22-gauge (Expect needle; Boston Scientific) needle: 15 to-and-fro movements within the lesion will be performed with simultaneous minimal negative pressure provi
Primary Outcome MeasuresMeasure DescriptionTime Frame
Diagnostic Yield of Capillary TechniqueDiagnostic yield is defined as percentage of specimens in which diagnostic material is obtained.up to 6 months
Diagnostic Yield of Standard TechniqueDiagnostic yield is defined as percentage of specimens in which diagnostic material is obtained.up to 6 months
Sensitivity of EUS-FNA With Capillary TechniqueSensitivity of the EUS-FNA with Capillary technique6 months
Sensitivity of EUS-FNA With StandardTechniqueSensitivity of the EUS-FNA with Capillary technique6 months
Sensitivity of EUS-FNAComparison of EUS-FNA sensitivity using Capillary technique versus Standard technique for pancreatic solid lesions6 months
Secondary Outcome MeasuresMeasure DescriptionTime Frame
First Pass Diagnostic RateThe rate of aquiring diagnostic pancreatic mass tissue with first FNA passimmediate
Acquisition of Core TissueThe rate of acquiring core tissue of the pancreatic mass through EUS-FNAimmediate
Diagnostic Accuracy of EUS-FNAThe proportion of subjects without the disease with negative EUS-FNA in total of subjects without the disease6 months

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:
    - In-patients and out-patients between the age of 18years and 90 years with pancreatic masses presenting for EUS-FNA
    Exclusion Criteria:

  • Uncorrectable coagulopathy (INR > 1.5)
  • Uncorrectable thrombocytopenia (platelet < 50,000)
  • Uncooperative patients
  • Pregnant women (women of childbearing age will undergo urine pregnancy testing, which is routine for all endoscopic procedures)
  • Refusal to consent form
  • Cystic lesions
  • Inaccessible lesions to EUS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • Boston Scientific Corporation

  • PRINCIPAL_INVESTIGATOR: Mouen A Khashab, MD, Johns Hopkins Univeristy

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Saxena P, El Zein M, Stevens T, Abdelgelil A, Besharati S, Messallam A, Kumbhari V, Azola A, Brainard J, Shin EJ, Lennon AM, Canto MI, Singh VK, Khashab MA. Stylet slow-pull versus standard suction for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic lesions: a multicenter randomized trial. Endoscopy. 2018 May;50(5):497-504. doi: 10.1055/s-0043-122381. Epub 2017 Dec 22.